Austria - Healthcare, Regulatory and Reimbursement Landscape

Published : Sep-2021

No. of Pages : 184

order by fax Inquire before Buying request discount

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Austrian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Austria
2.4 Key Events: Austria Healthcare Timeline, 2015-2021
2.5 Key Events: Austria Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Austria, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Austria
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Austria
3.7 COVID-19 Epidemiology, Austria
3.8 COVID-19 Impact and Developments in the Healthcare Market, Austria
3.9 COVID-19 Clinical Trials Landscape, Austria
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Austria, 2020-2021
6.2 Deal Analysis: Medical Device Market, Austria, 2020-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Austria
7.2 Adoption of Technology in Healthcare, Austria
7.3 HealthTech Deals Landscape, Austria
7.4 Key HealthTech Deals, Austria
7.5 Digital Health Regulations, Austria
7.7 COVID-19 Impact on Digital Health, Austria
7.8 HealthTech Landscape: Benefits and Risks, Austria
8. Market Access
8.1 Overview of Healthcare System, Austria
8.2 Reimbursement of Medicinal Products, Austria
8.3 Overview of Insurance Providers, Public Insurance, Austria
8.4 Overview of Insurance Providers, Private Insurance, Austria
8.5 Healthcare Spending and Prescription Drug Price Trend, Austria
8.6 Pricing Policies, Austria
8.7 Regulatory Landscape, Austria
8.7.1 Marketing Authorization for Pharmaceutical Products, EU
8.7.2 Market Authorization for Pharmaceutical Products (Centralized Procedure), Austria
8.7.3 Market Authorization for Pharmaceutical Products (Decentralized Procedure), Austria
8.7.4 Market Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Austria
8.7.5 Marketing Authorization for Pharmaceutical Products (National Procedure), Austria
8.7.6 Marketing Authorization for Medical Devices, Austria
8.7.7 Intellectual Property Rights, European Patent, Austria
8.7.8 Intellectual Property Rights, Unitary Patent, Austria
8.7.9 Intellectual Property Rights, Patent, Austria
8.7.10 Intellectual Property Rights, Trademark, Austria
8.7.11 Clinical Trial Regulation, Austria
8.7.12 Pharmaceutical Clinical Trials Landscape, Austria
8.7.13 Medical Devices Clinical Trials Landscape, Austria
8.7.14 Pharmaceutical Export and Import, Austria
8.7.15 Pharmaceutical Advertising Regulations, Austria
8.7.16 Pharmacy Regulations, Austria
8.7.17 Labeling and Packaging Regulations, Austria
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Austria
9.2 Healthcare Facilities, Austria
9.3 Healthcare Parameters, Austria
9.4 Life Expectancy and Immunization Rate, Austria
9.5 Environmental Health, Austria
9.6 Healthcare Personnel, Austria
9.7 Disease Burden, Austria
9.8 Healthcare Expenditure, Austria
9.9 Healthcare Spending Components and Pharmaceutical Spending, Austria
10 Trade Associations, Austria
11 Trade Fairs, Austria
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List of Tables
Table 1: Major Therapeutic Areas by Production Value ($M), Austria, 2019
Table 2: COVID-19 Indicators (Number of Cases), Global and Austria, 2020-2021
Table 3: COVID-19-Related Travel Restrictions, Austria, 2020-2021
Table 4: Approved Medical Devices for COVID-19, Austria, 2020-2021
Table 5: COVID-19 IVD Products, Austria, 2020-2021
Table 6: Medical Device Market, Austria, Major Segments ($B), 2020
Table 7: Hospital Supplies Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: General Surgery Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 9: Orthopedic Devices Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Cardiovascular Devices Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: Wound Care Management Market, Austria, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Digitization milestones, Austria, 2020
Table 13: Comparison between Private and Public Health Insurance, Austria, 2021
Table 14: Pharmacy Mark-Up Scheme for Privileged Customers, Austria, 2019
Table 15: Pharmacy Mark-Up Scheme for Private Customers, Austria, 2019
Table 16: Market Authorization Fees, Austria, 2021
Table 17: European Patent Fees, EU, 2021
Table 18: Fees for PRIO Registration, Austria, 2021
Table 19: Austrian Patent Annuities, Austria, 2021
Table 20: Fees for National Patent, Austria, 2021
Table 21: Difference between Patent and Utility Model, Austria, 2021
Table 22: Trademark Fees, Austria, 2021
Table 23: Fees of Clinical Trials with Medicinal Products, Austria, 2021
Table 24: Fees of Clinical Trials of Medical Devices, Austria, 2021
Table 25: Criteria for Establishing a New Pharmacy, Austria, 2020-2021

List of Figures
Figure 1: Pharmaceutical Market, Austria, Revenue ($B and B), 2012-2019
Figure 2: Medical Devices Market, Austria, Revenue ($B and B), 2015-2020
Figure 3: Healthcare Startups in Austria, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Value
Figure 6: Country Profile, Austria, 2020
Figure 7: Pharmaceutical Market, Austria, Revenue ($B and B), 2012-2019
Figure 8: Pharmaceutical Market, Austria, Revenue Forecast ($B and B), 2020-2025
Figure 9: Pharmaceutical Exports ($B), Austria, 2013-2020
Figure 10: Top Export Partners, Austria, 2020
Figure 11: Pharmaceutical Imports ($B), Austria, 2013-2020
Figure 12: Top Import Partners, Austria, 2020
Figure 13: Pharmaceutical Supply Channel , Austria, 2020
Figure 14: Working of ELGA, Austria, 2021
Figure 15: Generic Share by Volume (%), Austria, 2013-2019
Figure 16: Generic Share by Value (%), Austria, 2013-2019
Figure 17: OTC Medicines Market, Major Distribution Channels ($M), Austria, 2020
Figure 18: OTC Medicines Market, Revenue ($B), Austria, 2013-2020
Figure 19: OTC Medicines Market, Major Categories ($M), Austria, 2020
Figure 20: Major Therapeutic Areas by Production Value (%), Austria, 2019
Figure 21: COVID-19 Cases, Austria, 2020-2021
Figure 22: COVID-19 Deaths, Austria, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Austria, 2020-2021
Figure 24: COVID-19 Vaccination Progress, Austria, 2021
Figure 25: COVID-19 Vaccination Plan, Austria, 2021
Figure 26: COVID-19 Approved Vaccines, Austria, 2021
Figure 27: 3G Rule Evidences, Austria, 2021
Figure 28: COVID-19 Clinical Trials Count by Trial Status, Austria, 2020-2021
Figure 29: COVID-19 Top Market Categories by Clinical Trials, Austria, 2020-2021
Figure 30: Top Six COVID-19 Clinical Trials Sponsors by Trial Count, Austria, 2020-2021
Figure 31: Medical Devices Market, Austria, Revenue ($B), 2015-2020
Figure 32: Medical Devices Market, Austria, Revenue Forecast ($B), 2021-2025
Figure 33: Medical Device Market, Austria, Major Segments (%), 2020
Figure 34: Hospital Supplies Market, Austria, Revenue ($B), 2017-2025
Figure 35: Hospital Supplies Market, Austria, Market Share of Major Players (%), 2020
Figure 36: General Surgery Market, Austria, Revenue ($M), 2017-2025
Figure 37: General Surgery Market, Austria, Market Share of Major Players (%), 2020
Figure 38: Orthopedic Devices Market, Austria, Revenue ($M), 2017-2025
Figure 39: Orthopedic Devices Market, Austria, Market Share of Major Players (%), 2020
Figure 40: Cardiovascular Devices Market, Austria, Revenue ($M), 2017-2025
Figure 41: Cardiovascular Devices Market, Austria, Market Share of Major Players (%), 2020
Figure 42: Wound Care Management Market, Austria, Revenue ($M), 2017-2025
Figure 43: Wound Care Management Market, Austria, Market Share of Major Players (%), 2020
Figure 44: Diagnostics Market, Austria, Revenue ($M), 2015-2020
Figure 45: Diagnostics Market, Austria, Revenue Forecast ($M), 2021-2025
Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Austria, 2019-2021
Figure 47: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Austria, 2019-2021
Figure 48: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Austria, 2019-2021
Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Austria, 2019-2021
Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Austria, 2019-2021
Figure 51: M&A Deals by Quarter, Pharmaceutical Market, Austria, 2019-2021 (by Value and by Number)
Figure 52: VC Deals by Quarter, Pharmaceutical Market, Austria, 2019-2021 (by Value and by Number)
Figure 53: Deal Value and Deal Count, Medical Devices Market, Austria, 2019-2021
Figure 54: Deal Value and Deal Count Sub-types, Medical Devices Market, Austria, 2019-2021
Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Austria, 2019-2021
Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Austria, 2019-2021
Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Austria, 2019-2021
Figure 58: M&A Deals by Equipment Sector, Medical Devices Market, Austria, 2019-2021 (by Value and by Number)
Figure 59: VC Deals by Quarter, Medical Devices Market, Austria, 2019-2021 (by Value and by Number)
Figure 60: Deal Value ($M) and Deal Count, HealthTech, Austria, 2020-2021
Figure 61: Deal Value and Deal Count (Number of Deals) by sector, HealthTech, Austria, 2020-2021
Figure 62: Digital RoadMap and 12 Guiding Principles, Austria, 2020
Figure 63: Measures defined by Digital Roadmap in the Field of Health, Austria, 2020
Figure 64: GDPR Compliance Checklist, EU, 2021
Figure 65: Digital Health Areas Affected by COVID-19, Austria, 2021
Figure 66: Key Organizations and People of Healthcare System, Austria, 2021
Figure 67: Organization of Austrian Healthcare System, Austria, 2021
Figure 68: Reimbursement of Medicines, Austria, 2021
Figure 69: Financial Flow, Austria, 2021
Figure 70: Budget of Health Insurance Institutions (%), Austria, 2018
Figure 71: Umbrella Organization, Austria, 2021
Figure 72: OOP Expenditure (% of Total Expenditure on Health), Austria, 2013-2020
Figure 73: Annual Average Rate of Change (%), Health Price Index, Austria, 2012-2020
Figure 74: BASG Organizational Structure, Austria, 2021
Figure 75: Marketing Authorization for Pharmaceutical Products, EU, 2020
Figure 76: Centralized Procedure, EU, 2021
Figure 77: Decentralized Procedure, EU, 2021
Figure 78: Mutual Recognition Procedure, EU, 2021
Figure 79: Conformity Assessment of Class I Medical Devices, EU, 2019
Figure 80: Conformity Assessment of Class IIa Medical Devices, EU, 2019
Figure 81: Conformity Assessment of Class IIb Medical Devices, EU, 2019
Figure 82: Conformity Assessment of Class III Medical Devices, EU, 2019
Figure 83: European Patent Approval Process, EU, 2020

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Austria - Healthcare, Regulatory and Reimbursement Landscape

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027